2m 2m 2m 2m 2m 2m 2m
SAB BIOTHERAP (SABS)
NASDAQ
$3.09-$0.02 (-0.68%)
Price as of Nov 12, 2026 7:00 AM EST- $280.2MMarket Cap
- -8.80%1-Year Change
- BiotechnologyIndustry
SAB BIOTHERAP (SABS)
$3.09-$0.02 (-0.68%)
Earnings Score
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -28.72% | ||
12-Month Momentum | -18.04% | ||
3-Month Risk Adjusted Momentum | -169.39% | ||
12-Month Risk Adjusted Momentum | -31.67% |
True Yield
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.60% |
Financial Health Score
Valuation | SABS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 2 |